These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 15008843
1. No nephropathy in Type 2 diabetic patient with POEMS syndrome with an elevated plasma VEGF. Baba T, Østerby R, Neugebauer-Baba S, Nozawa Y, Watanabe T, Sakurai K, Katoh T, Watanabe T. Diabet Med; 2004 Mar; 21(3):292-4. PubMed ID: 15008843 [Abstract] [Full Text] [Related]
2. VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome. Niimi H, Arimura K, Jonosono M, Hashiguchi T, Kawabata M, Osame M, Kitajima I. Intern Med; 2000 Dec; 39(12):1101-4. PubMed ID: 11197800 [Abstract] [Full Text] [Related]
3. VEGF and osteosclerosis in POEMS syndrome. Gütgemann I, Stevens K, Loftus D, Schmidt-Wolf IG, George TI. Ann Hematol; 2008 Mar; 87(3):243-5. PubMed ID: 18172647 [No Abstract] [Full Text] [Related]
4. Multiple vascular abnormalities and a paradoxical combination of vitamin B12 deficiency and thrombocytosis in a case with POEMS syndrome. Lewerenz J, Gocht A, Hoeger PH, von den Driesch P, Eckert B, Lamszus K, Stuerenburg HJ, Methner A. J Neurol; 2003 Dec; 250(12):1488-91. PubMed ID: 14673584 [Abstract] [Full Text] [Related]
5. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome. Yokouchi H, Baba T, Misawa S, Oshitari T, Kuwabara S, Yamamoto S. Br J Ophthalmol; 2020 Jan; 104(1):33-38. PubMed ID: 30914422 [Abstract] [Full Text] [Related]
6. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus. Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR. Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937 [Abstract] [Full Text] [Related]
18. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Hovind P, Tarnow L, Oestergaard PB, Parving HH. Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763 [Abstract] [Full Text] [Related]
19. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, De Vriese AS. Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198 [Abstract] [Full Text] [Related]